Amgen Inc (AMGN)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$321.25

Buy

$327.75

arrow-down$-1.59 (-0.49%)

Prices updated at 19 Dec 2025, 00:59 EST

Prices minimum 15 mins delay

Prices in USD

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

NASDAQ

1.38%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$328.24 - $321.91
	$346.38 - $253.30
	2.76
	175,550.08m
	25.21
	-
	2,669,255
	18.25
	2,791,637.65
	0.21
	537.00m
	US0311621009
	12.93
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.